Shvabe Holding (part of Rostec State Corporation) and Peter the Great St. Petersburg Polytechnic University are working together to create the first Russian equipment for non-invasive tumor treatment. The production of this new high-intensity focused ultrasound (HIFU) system will be organized in the Novosibirsk Instrument-making plant and first prototypes will be created by the end of 2019.
The HIFU system, that includes both hardware and software, will be designed for diagnostics and treatment of tumors in the mammary gland using focused high-intensity ultrasound. The system will consist of a power module, a medical stand with a monitor and control panel, a robotic manipulator unit, the ultrasound unit with a combined ultrasonic piezoelectric transducer for both diagnostics and treatment and the patient’s seat with an immobilizer.
“Rostec continues to expand its range of medical equipment. We are creating live-saving high-tech medical devices in partnership with leading Russian universities. Non-invasive treatment is one of the safest ways to treat cancer. Our HIFU system will have several advantages compared to foreign analogues: it will be more compact and easier to use. It will also include electronic guidance and continuous monitoring of the ultrasound effect on the tumor”, said Oleg Evtushenko, the Executive Director of Rostec.
Technical and design development work has already been completed; now the project team is working on the documentation along with system application methods. First prototype of the system will be created by the end of 2019, and first clinical tests could be conducted in 2020. After this, the project can obtain a registration certificate and start mass production.
“We see great potential for the supply of our high-tech medical equipment to highly-populated developing countries like India, China and the countries of Southeast Asia and Latin America”, pointed Viktor Kladov, the Director for International Cooperation and Regional Policy Department of Rostec. “I’m confident that the new HIFU system, created by leading Russian specialists, will have appropriate demand in many foreign markets.”
The project is financed by Novosibirsk Instrument-making plant, subsidiary of Shvabe Holding. The plant will later organize the mass production of the product.
In the future, a whole new line of analogous devices might be created based on this project. These include devices intended for the treatment of tumors in the liver, prostate gland and brain.
